randomized clinical comparison of daunorubicin ( nsc-82151 ) alone with a combination of daunorubicin , cytosine arabinoside ( nsc-63878 ) , 6-thioguanine ( nsc-752 ) , and pyrimethamine ( nsc-3061 ) for the treatment of acute nonlymphocytic leukemia .
C0011015
daunorubicin
C0023467
acute